Clinical and Experimental Hypertension

Title Publication Date Language Citations
1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension1999/01/01English309
The Blood Pressure-Lowering Effect and Safety of Chlorogenic Acid from Green Coffee Bean Extract in Essential Hypertension2006/01/01English160
Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension2013/06/20English120
The Effect of Cognitive Behavior Therapy-Based “Forest Therapy” Program on Blood Pressure, Salivary Cortisol Level, and Quality of Life in Elderly Hypertensive Patients2011/10/18English117
The Effects of Blood Pressure Reduction in Older Patients: An Overview of Five Randomized Controlled Trials in Elderly Hypertensives1993/01/01English109
The Consequences of Traumatic Brain Injury on Cerebral Blood Flow and Autoregulation: A Review1999/01/01English98
The Renin — Angiotensin — Aldosterone System in Pre-Eclampsia1997/01/01English89
Simultaneous Measurement of Marinobufagenin, Ouabain, and Hypertension-associated Protein In Various Disease States1998/01/01English88
Nimodipine and Its Use in Cerebrovascular Disease: Evidence from Recent Preclinical and Controlled Clinical Studies2008/01/01English84
Mechanisms of Insulin Action on Sympathetic Nerve Activity1995/01/01English84
The Comparative Effects of Valsartan and Amlodipine on vWf Levels and N/L Ratio in Patients with Newly Diagnosed Hypertension2013/01/04English82
The Cellular Mechanism of Action of Cardiotonic Steroids: A New Hypothesis1998/01/01English82
Effect of Dietary Fiber and Protein Intake on Blood Pressure: A Review of Epidemiologic Evidence1999/01/01English79
Protective Effects of Candesartan Cilexetil (TCV-116) Against Stroke, Kidney Dysfunction and Cardiac Hypertrophy in Stroke-Prone Spontaneously Hypertensive Rats1997/01/01English77
Anti-Hypertensive Effect of γ-Aminobutyric Acid (GABA)-RichChlorellaon High-Normal Blood Pressure and Borderline Hypertension in Placebo-Controlled Double Blind Study2009/01/01English75
Endogenous Marinobufagenin-Like Factor In Acute Plasma Volume Expansion1998/01/01English74
Observations on the Nature, Biosynthesis, Secretion and Significance of Endogenous Ouabain1998/01/01English74
Direct Vasoactive Effects of the Chromogranin A (CHGA) Peptide Catestatin in HumansIn Vivo2010/07/27English69
Functional Anatomy of Sympathetic Premotor Cell Groups in the Medulla1995/01/01English66
Plasma Apelin and ADMA Levels in Patients with Essential Hypertension2010/05/01English65
Compliance with Antihypertensive Therapy1999/01/01English65
Cardiovascular and Endocrine Effects of Acupuncture in Hypertensive Patients1997/01/01English64
Matrix Metalloproteinases: Discrete Elevations in Essential Hypertension and Hypertensive End-Stage Renal Disease2009/11/01English63
Association and interaction between triglyceride–glucose index and obesity on risk of hypertension in middle-aged and elderly adults2017/07/24English62
Molecular genetics of essential hypertension2016/03/30English61
Use of C-Fos Functional Mapping to Identify the Central Baroreceptor Reflex Pathway: Advantages and Limitations1995/01/01English60
Combined exercise training reduces blood pressure, arterial stiffness, and insulin resistance in obese prehypertensive adolescent girls2017/06/07English60
Integration in the Ventral Medulla and Coordination of Sympathetic, Pain and Arousal Functions1995/01/01English60
Circulating miR-21 and eNOS in subclinical atherosclerosis in patients with hypertension2015/06/26English59
The Evidence for a Pathophysiologic Significance of the Sympathetic Overactivity in Hypertension1996/01/01English59